A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male Subjects
← catalyst calendarSponsored by Celltrion (industry) · 068270.KS — their whole pipeline →.
Phase
Phase 1
Status
Completed
Study type
Interventional
Design
Randomized · None · Other
Enrollment
162actual
Sites
1
Country
South Korea
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-05-30 | actual | When the study began enrolling |
| Primary completion | 2025-11-26 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-12-24 | actual | The whole study's end, after follow-up |
| First posted | 2025-04-30 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-02-24 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Healthy Male Subjects
Interventions
- Biological: CT-P43
- Biological: CT-P43
Primary outcomes
what the primary-completion date above is the date OFPK similarity demonstration by AUC 0-inf
measured Day113
PK similarity demonstration by Cmax
measured Day113
Permalink · 068270.KS's whole pipeline · Catalyst calendar · Every registered study · What changed